The author summarizes the efficacy of two inhaled agents—ipratropium bromide (Atrovent HFA) and tiotropium bromide (Spiriva)—in reducing dyspnea, bronchoconstriction, the frequency of disease exacerbation, and in improving patients’ health status.
You are here
P&T® Journal contents for March 2007
Two biologic agents are featured: infliximab (Remicade), which is approved for the treatment of ulcerative colitis, and adalimumab (Humira), indicated for patients with Crohn’s disease.
The author discusses paliperidone (Invega) for the treatment of schizophrenia; telbivudine (Tyzeka) for patients with chronic hepatitis B infection; and a combination of clindamycin phosphate and tretinoin (Ziana Gel) as a topical therapy for acne vulgaris.
Continuing Education Credit
Geriatric depression is often overlooked. The authors review the epidemiology, diagnosis, pathophysiology, and treatment of depression in older adults, with an emphasis on newer pharmacotherapeutic agents.